ArticleTrials2020

Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF).

Ruth Nabisere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.